Wednesday, March 29, 2017
CordenPharma is a full-service Contract Development & Manufacturing Organization (CDMO) organized under five Technology Platforms – Peptides, Oligonucleotides, Lipids, & Carbohydrates – Injectables - Highly Potent & Oncology - Small Molecules – Antibiotics.
CordenPharma Colorado, one of multiple cGMP CordenPharma facilities located across Europe and the US, plays an important role in the 3 out of 5 Technology Platforms through the manufacture of peptides, oligonucleotides, highly potent APIs and small molecules.
CordenPharma Colorado's chemists and engineers are widely recognized for their history of innovation, having developed highly efficient drug substance manufacturing processes for some of the world's most complex pharmaceutical compounds.
With the flexibility to handle sophisticated manufacturing techniques while readily adapting to the ever changing market demand for new products, CordenPharma Colorado contributes greatly to the integrated resource of experts at CordenPharma, making them one of the most respected CDMOs in the pharma industry, which ultimately benefits the lives of the patients worldwide.